On August 21, 2020 Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, reported that it will be releasing its Fiscal 2020 Third Quarter financial results on Monday August 24th, 2020, before markets open (Press release, Covalon Technologies, AUG 21, 2020, View Source [SID1234563933]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A conference call to discuss Covalon’s Fiscal 2020 Q3 Financial Results will be held on Monday August 24th, 2020, at 9:00am EST. To participate in the call, please dial:

Local: 416.764.8659
North American Toll-Free: 1.888.664.6392
Confirmation Number: 80896464

A recording of the call will be available until September 7th, 2020, by calling 416.764.8677 or 1.888.390.0541 and entering the encore replay entry code 896464#. A recording of the call will also be available at View Source

Copies of Covalon’s financial statements and MD&A can be obtained on SEDAR at www.sedar.com, as well as at View Source